Johnson & Johnson (JNJ) Gains As Market Dips

Johnson & Johnson (JNJ) closed at $168.45 in the latest trading session, marking a +1.79% move from the prior day. The stock outpaced the S&P 500's daily loss of 0.91%. Elsewhere, the Dow lost 0.89%, while the tech-heavy Nasdaq lost 0.12%.

Prior to today's trading, shares of the world's biggest maker of health care products had gained 0.29% over the past month. This has outpaced the Medical sector's loss of 3.31% and lagged the S&P 500's gain of 1.55% in that time.

Investors will be hoping for strength from Johnson & Johnson as it approaches its next earnings release, which is expected to be January 25, 2022. The company is expected to report EPS of $2.12, up 13.98% from the prior-year quarter. Meanwhile, the latest consensus estimate is calling for revenue of $25.26 billion, up 12.37% from the prior-year quarter.

Investors should also note any recent changes to analyst estimates for Johnson & Johnson. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.

Contents excerpt from Yahoo Finance.